Massmutual Trust CO Fsb Sarepta Therapeutics, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.7 Billion
- Q2 2025
A detailed history of Massmutual Trust CO Fsb transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 328 shares of SRPT stock, worth $5,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
328
Previous 198
65.66%
Holding current value
$5,992
Previous $12,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SRPT
# of Institutions
464Shares Held
83.3MCall Options Held
5.48MPut Options Held
4.15M-
Black Rock Inc. New York, NY10.3MShares$189 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$167 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$85.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$81.8 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$46.2 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...